Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
Identifieur interne : 000447 ( PubMed/Corpus ); précédent : 000446; suivant : 000448Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
Auteurs : Yen T. Duong ; Reshma Kassanjee ; Alex Welte ; Meade Morgan ; Anindya De ; Trudy Dobbs ; Erin Rottinghaus ; John Nkengasong ; Marcel E. Curlin ; Chonticha Kittinunvorakoon ; Boonyos Raengsakulrach ; Michael Martin ; Kachit Choopanya ; Suphak Vanichseni ; Yan Jiang ; Maofeng Qiu ; Haiying Yu ; Yan Hao ; Neha Shah ; Linh-Vi Le ; Andrea A. Kim ; Tuan Anh Nguyen ; William Ampofo ; Bharat S. ParekhSource :
- PloS one [ 1932-6203 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- chemical , immunology : HIV Antigens.
- classification : HIV-1.
- diagnosis : HIV Seropositivity.
- epidemiology : HIV Seropositivity.
- genetics : HIV-1.
- immunology : HIV-1.
- standards : Immunoenzyme Techniques, Serologic Tests.
- Antibody Affinity, Calibration, Humans.
Abstract
Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as proportion false recent (PFR), are critical parameters for laboratory-based assays for estimating HIV-1 incidence. Recent review of the data by us and others indicated that MDRI of LAg-Avidity EIA estimated previously required recalibration. We present here results of recalibration efforts using >250 seroconversion panels and multiple statistical methods to ensure accuracy and consensus.
DOI: 10.1371/journal.pone.0114947
PubMed: 25710171
Links to Exploration step
pubmed:25710171Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.</title><author><name sortKey="Duong, Yen T" sort="Duong, Yen T" uniqKey="Duong Y" first="Yen T" last="Duong">Yen T. Duong</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Kassanjee, Reshma" sort="Kassanjee, Reshma" uniqKey="Kassanjee R" first="Reshma" last="Kassanjee">Reshma Kassanjee</name><affiliation><nlm:affiliation>The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch, Stellenbosch, South Africa; School of Computational and Applied Mathematics, University of the Witwatersrand, Johannesburg, South Africa.</nlm:affiliation></affiliation></author><author><name sortKey="Welte, Alex" sort="Welte, Alex" uniqKey="Welte A" first="Alex" last="Welte">Alex Welte</name><affiliation><nlm:affiliation>The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch, Stellenbosch, South Africa.</nlm:affiliation></affiliation></author><author><name sortKey="Morgan, Meade" sort="Morgan, Meade" uniqKey="Morgan M" first="Meade" last="Morgan">Meade Morgan</name><affiliation><nlm:affiliation>Epidemiology and Strategic Information Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="De, Anindya" sort="De, Anindya" uniqKey="De A" first="Anindya" last="De">Anindya De</name><affiliation><nlm:affiliation>Epidemiology and Strategic Information Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Dobbs, Trudy" sort="Dobbs, Trudy" uniqKey="Dobbs T" first="Trudy" last="Dobbs">Trudy Dobbs</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Rottinghaus, Erin" sort="Rottinghaus, Erin" uniqKey="Rottinghaus E" first="Erin" last="Rottinghaus">Erin Rottinghaus</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Nkengasong, John" sort="Nkengasong, John" uniqKey="Nkengasong J" first="John" last="Nkengasong">John Nkengasong</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Curlin, Marcel E" sort="Curlin, Marcel E" uniqKey="Curlin M" first="Marcel E" last="Curlin">Marcel E. Curlin</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Kittinunvorakoon, Chonticha" sort="Kittinunvorakoon, Chonticha" uniqKey="Kittinunvorakoon C" first="Chonticha" last="Kittinunvorakoon">Chonticha Kittinunvorakoon</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Raengsakulrach, Boonyos" sort="Raengsakulrach, Boonyos" uniqKey="Raengsakulrach B" first="Boonyos" last="Raengsakulrach">Boonyos Raengsakulrach</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Martin, Michael" sort="Martin, Michael" uniqKey="Martin M" first="Michael" last="Martin">Michael Martin</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Choopanya, Kachit" sort="Choopanya, Kachit" uniqKey="Choopanya K" first="Kachit" last="Choopanya">Kachit Choopanya</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Vanichseni, Suphak" sort="Vanichseni, Suphak" uniqKey="Vanichseni S" first="Suphak" last="Vanichseni">Suphak Vanichseni</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Jiang, Yan" sort="Jiang, Yan" uniqKey="Jiang Y" first="Yan" last="Jiang">Yan Jiang</name><affiliation><nlm:affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Qiu, Maofeng" sort="Qiu, Maofeng" uniqKey="Qiu M" first="Maofeng" last="Qiu">Maofeng Qiu</name><affiliation><nlm:affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yu, Haiying" sort="Yu, Haiying" uniqKey="Yu H" first="Haiying" last="Yu">Haiying Yu</name><affiliation><nlm:affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Hao, Yan" sort="Hao, Yan" uniqKey="Hao Y" first="Yan" last="Hao">Yan Hao</name><affiliation><nlm:affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Shah, Neha" sort="Shah, Neha" uniqKey="Shah N" first="Neha" last="Shah">Neha Shah</name><affiliation><nlm:affiliation>California Department of Public Health, Richmond, California, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Le, Linh Vi" sort="Le, Linh Vi" uniqKey="Le L" first="Linh-Vi" last="Le">Linh-Vi Le</name><affiliation><nlm:affiliation>Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Hanoi, Vietnam.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Andrea A" sort="Kim, Andrea A" uniqKey="Kim A" first="Andrea A" last="Kim">Andrea A. Kim</name><affiliation><nlm:affiliation>CDC-Kenya, Nairobi, Kenya.</nlm:affiliation></affiliation></author><author><name sortKey="Nguyen, Tuan Anh" sort="Nguyen, Tuan Anh" uniqKey="Nguyen T" first="Tuan Anh" last="Nguyen">Tuan Anh Nguyen</name><affiliation><nlm:affiliation>National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.</nlm:affiliation></affiliation></author><author><name sortKey="Ampofo, William" sort="Ampofo, William" uniqKey="Ampofo W" first="William" last="Ampofo">William Ampofo</name><affiliation><nlm:affiliation>Noguchi Memorial Institute for Medical Research, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Parekh, Bharat S" sort="Parekh, Bharat S" uniqKey="Parekh B" first="Bharat S" last="Parekh">Bharat S. Parekh</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25710171</idno><idno type="pmid">25710171</idno><idno type="doi">10.1371/journal.pone.0114947</idno><idno type="wicri:Area/PubMed/Corpus">000447</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000447</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.</title><author><name sortKey="Duong, Yen T" sort="Duong, Yen T" uniqKey="Duong Y" first="Yen T" last="Duong">Yen T. Duong</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Kassanjee, Reshma" sort="Kassanjee, Reshma" uniqKey="Kassanjee R" first="Reshma" last="Kassanjee">Reshma Kassanjee</name><affiliation><nlm:affiliation>The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch, Stellenbosch, South Africa; School of Computational and Applied Mathematics, University of the Witwatersrand, Johannesburg, South Africa.</nlm:affiliation></affiliation></author><author><name sortKey="Welte, Alex" sort="Welte, Alex" uniqKey="Welte A" first="Alex" last="Welte">Alex Welte</name><affiliation><nlm:affiliation>The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch, Stellenbosch, South Africa.</nlm:affiliation></affiliation></author><author><name sortKey="Morgan, Meade" sort="Morgan, Meade" uniqKey="Morgan M" first="Meade" last="Morgan">Meade Morgan</name><affiliation><nlm:affiliation>Epidemiology and Strategic Information Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="De, Anindya" sort="De, Anindya" uniqKey="De A" first="Anindya" last="De">Anindya De</name><affiliation><nlm:affiliation>Epidemiology and Strategic Information Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Dobbs, Trudy" sort="Dobbs, Trudy" uniqKey="Dobbs T" first="Trudy" last="Dobbs">Trudy Dobbs</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Rottinghaus, Erin" sort="Rottinghaus, Erin" uniqKey="Rottinghaus E" first="Erin" last="Rottinghaus">Erin Rottinghaus</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Nkengasong, John" sort="Nkengasong, John" uniqKey="Nkengasong J" first="John" last="Nkengasong">John Nkengasong</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Curlin, Marcel E" sort="Curlin, Marcel E" uniqKey="Curlin M" first="Marcel E" last="Curlin">Marcel E. Curlin</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Kittinunvorakoon, Chonticha" sort="Kittinunvorakoon, Chonticha" uniqKey="Kittinunvorakoon C" first="Chonticha" last="Kittinunvorakoon">Chonticha Kittinunvorakoon</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Raengsakulrach, Boonyos" sort="Raengsakulrach, Boonyos" uniqKey="Raengsakulrach B" first="Boonyos" last="Raengsakulrach">Boonyos Raengsakulrach</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Martin, Michael" sort="Martin, Michael" uniqKey="Martin M" first="Michael" last="Martin">Michael Martin</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Choopanya, Kachit" sort="Choopanya, Kachit" uniqKey="Choopanya K" first="Kachit" last="Choopanya">Kachit Choopanya</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Vanichseni, Suphak" sort="Vanichseni, Suphak" uniqKey="Vanichseni S" first="Suphak" last="Vanichseni">Suphak Vanichseni</name><affiliation><nlm:affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Jiang, Yan" sort="Jiang, Yan" uniqKey="Jiang Y" first="Yan" last="Jiang">Yan Jiang</name><affiliation><nlm:affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Qiu, Maofeng" sort="Qiu, Maofeng" uniqKey="Qiu M" first="Maofeng" last="Qiu">Maofeng Qiu</name><affiliation><nlm:affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Yu, Haiying" sort="Yu, Haiying" uniqKey="Yu H" first="Haiying" last="Yu">Haiying Yu</name><affiliation><nlm:affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Hao, Yan" sort="Hao, Yan" uniqKey="Hao Y" first="Yan" last="Hao">Yan Hao</name><affiliation><nlm:affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</nlm:affiliation></affiliation></author><author><name sortKey="Shah, Neha" sort="Shah, Neha" uniqKey="Shah N" first="Neha" last="Shah">Neha Shah</name><affiliation><nlm:affiliation>California Department of Public Health, Richmond, California, United States of America.</nlm:affiliation></affiliation></author><author><name sortKey="Le, Linh Vi" sort="Le, Linh Vi" uniqKey="Le L" first="Linh-Vi" last="Le">Linh-Vi Le</name><affiliation><nlm:affiliation>Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Hanoi, Vietnam.</nlm:affiliation></affiliation></author><author><name sortKey="Kim, Andrea A" sort="Kim, Andrea A" uniqKey="Kim A" first="Andrea A" last="Kim">Andrea A. Kim</name><affiliation><nlm:affiliation>CDC-Kenya, Nairobi, Kenya.</nlm:affiliation></affiliation></author><author><name sortKey="Nguyen, Tuan Anh" sort="Nguyen, Tuan Anh" uniqKey="Nguyen T" first="Tuan Anh" last="Nguyen">Tuan Anh Nguyen</name><affiliation><nlm:affiliation>National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.</nlm:affiliation></affiliation></author><author><name sortKey="Ampofo, William" sort="Ampofo, William" uniqKey="Ampofo W" first="William" last="Ampofo">William Ampofo</name><affiliation><nlm:affiliation>Noguchi Memorial Institute for Medical Research, Accra, Ghana.</nlm:affiliation></affiliation></author><author><name sortKey="Parekh, Bharat S" sort="Parekh, Bharat S" uniqKey="Parekh B" first="Bharat S" last="Parekh">Bharat S. Parekh</name><affiliation><nlm:affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</nlm:affiliation></affiliation></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibody Affinity</term><term>Calibration</term><term>HIV Antigens (immunology)</term><term>HIV Seropositivity (diagnosis)</term><term>HIV Seropositivity (epidemiology)</term><term>HIV-1 (classification)</term><term>HIV-1 (genetics)</term><term>HIV-1 (immunology)</term><term>Humans</term><term>Immunoenzyme Techniques (standards)</term><term>Serologic Tests (standards)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>HIV Antigens</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>HIV-1</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>HIV Seropositivity</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>HIV Seropositivity</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>HIV-1</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV-1</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Immunoenzyme Techniques</term><term>Serologic Tests</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Antibody Affinity</term><term>Calibration</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as proportion false recent (PFR), are critical parameters for laboratory-based assays for estimating HIV-1 incidence. Recent review of the data by us and others indicated that MDRI of LAg-Avidity EIA estimated previously required recalibration. We present here results of recalibration efforts using >250 seroconversion panels and multiple statistical methods to ensure accuracy and consensus.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25710171</PMID><DateCreated><Year>2015</Year><Month>02</Month><Day>25</Day></DateCreated><DateCompleted><Year>2016</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.</ArticleTitle><Pagination><MedlinePgn>e0114947</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0114947</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Mean duration of recent infection (MDRI) and misclassification of long-term HIV-1 infections, as proportion false recent (PFR), are critical parameters for laboratory-based assays for estimating HIV-1 incidence. Recent review of the data by us and others indicated that MDRI of LAg-Avidity EIA estimated previously required recalibration. We present here results of recalibration efforts using >250 seroconversion panels and multiple statistical methods to ensure accuracy and consensus.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 2737 longitudinal specimens collected from 259 seroconverting individuals infected with diverse HIV-1 subtypes were tested with the LAg-Avidity EIA as previously described. Data were analyzed for determination of MDRI at ODn cutoffs of 1.0 to 2.0 using 7 statistical approaches and sub-analyzed by HIV-1 subtypes. In addition, 3740 specimens from individuals with infection >1 year, including 488 from patients with AIDS, were tested for PFR at varying cutoffs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Using different statistical methods, MDRI values ranged from 88-94 days at cutoff ODn = 1.0 to 177-183 days at ODn = 2.0. The MDRI values were similar by different methods suggesting coherence of different approaches. Testing for misclassification among long-term infections indicated that overall PFRs were 0.6% to 2.5% at increasing cutoffs of 1.0 to 2.0, respectively. Balancing the need for a longer MDRI and smaller PFR (<2.0%) suggests that a cutoff ODn = 1.5, corresponding to an MDRI of 130 days should be used for cross-sectional application. The MDRI varied among subtypes from 109 days (subtype A&D) to 152 days (subtype C).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on the new data and revised analysis, we recommend an ODn cutoff = 1.5 to classify recent and long-term infections, corresponding to an MDRI of 130 days (118-142). Determination of revised parameters for estimation of HIV-1 incidence should facilitate application of the LAg-Avidity EIA for worldwide use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duong</LastName><ForeName>Yen T</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassanjee</LastName><ForeName>Reshma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch, Stellenbosch, South Africa; School of Computational and Applied Mathematics, University of the Witwatersrand, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welte</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), University of Stellenbosch, Stellenbosch, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Meade</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Epidemiology and Strategic Information Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De</LastName><ForeName>Anindya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Epidemiology and Strategic Information Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobbs</LastName><ForeName>Trudy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rottinghaus</LastName><ForeName>Erin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nkengasong</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curlin</LastName><ForeName>Marcel E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kittinunvorakoon</LastName><ForeName>Chonticha</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raengsakulrach</LastName><ForeName>Boonyos</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choopanya</LastName><ForeName>Kachit</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanichseni</LastName><ForeName>Suphak</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Thailand Ministry of Public Health-US CDC Collaboration, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Maofeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Haiying</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National AIDS Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Neha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>California Department of Public Health, Richmond, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Linh-Vi</ForeName><Initials>LV</Initials><AffiliationInfo><Affiliation>Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Andrea A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>CDC-Kenya, Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Tuan Anh</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ampofo</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Noguchi Memorial Institute for Medical Research, Accra, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parekh</LastName><ForeName>Bharat S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>PEPFAR</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015488">HIV Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Med Sci Monit. 2011 May;17(5):RA124-33</RefSource><PMID Version="1">21525823</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiology. 2010 Sep;21(5):685-97</RefSource><PMID Version="1">20699682</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2012;7(3):e33328</RefSource><PMID Version="1">22479384</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2013 Jan 15;207(2):232-9</RefSource><PMID Version="1">23129760</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(5):e5720</RefSource><PMID Version="1">19479050</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Stat Med. 2010 Dec 30;29(30):3194-202</RefSource><PMID Version="1">21170913</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1987 Jun;125(6):1048-57</RefSource><PMID Version="1">3495173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2003 Jun;19(6):481-6</RefSource><PMID Version="1">12882657</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2011 Jul;49(7):2610-3</RefSource><PMID Version="1">21543577</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2008 Apr 8;5(4):e80</RefSource><PMID Version="1">18590346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2010 Jan;26(1):61-71</RefSource><PMID Version="1">20063992</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2005 May;19 Suppl 2:S25-30</RefSource><PMID Version="1">15930838</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Euro Surveill. 2010;15(24). pii: 19589</RefSource><PMID Version="1">20576235</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2012 Sep 1;206(5):756-64</RefSource><PMID Version="1">22826337</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Epidemiology. 2012 Sep;23(5):721-8</RefSource><PMID Version="1">22627902</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):94-103</RefSource><PMID Version="1">12514420</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2008 Feb 19;22(4):511-8</RefSource><PMID Version="1">18301064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):625-34</RefSource><PMID Version="1">12902808</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2013 Jan;29(1):61-7</RefSource><PMID Version="1">23281586</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):424-8</RefSource><PMID Version="1">12640201</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2013 Feb 1;177(3):264-72</RefSource><PMID Version="1">23302151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2005 Sep;43(9):4441-7</RefSource><PMID Version="1">16145089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sex Health. 2008 Jun;5(2):169-87</RefSource><PMID Version="1">18686336</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2004 Jan 15;189(2):303-11</RefSource><PMID Version="1">14722896</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1998 Jul 1;280(1):42-8</RefSource><PMID Version="1">9660362</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 1997 Sep 15;146(6):459-69</RefSource><PMID Version="1">9290506</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2010 Nov 27;24(18):2763-71</RefSource><PMID Version="1">20975514</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2012 Feb;28(2):188-97</RefSource><PMID Version="1">21585287</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Diagn Lab Immunol. 2005 Aug;12(8):918-21</RefSource><PMID Version="1">16085908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Drug Policy. 2008 Apr;19 Suppl 1:S65-73</RefSource><PMID Version="1">18207726</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Infect Genet Evol. 2013 Aug;18:125-31</RefSource><PMID Version="1">23583545</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Epidemiol. 2002 Jan 15;155(2):159-68</RefSource><PMID Version="1">11790680</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2008;3(5):e2212</RefSource><PMID Version="1">18493593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2013 Jan 15;207(2):223-31</RefSource><PMID Version="1">23129758</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J HIV AIDS Surveill Epidemiol. 2010 Jan 1;2(1):1-14</RefSource><PMID Version="1">21743821</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2011 Mar;27(3):265-73</RefSource><PMID Version="1">20954834</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2004 Nov 19;18(17):2253-9</RefSource><PMID Version="1">15577537</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2013 Jan 15;207(2):204-6</RefSource><PMID Version="1">23129757</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sex Transm Infect. 2010 Dec;86 Suppl 2:ii3-10</RefSource><PMID Version="1">20929855</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Indian J Med Res. 2005 Apr;121(4):510-8</RefSource><PMID Version="1">15817960</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2001 Mar 20;17(5):453-8</RefSource><PMID Version="1">11282014</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2002 Mar 1;18(4):295-307</RefSource><PMID Version="1">11860677</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sex Transm Infect. 2008 Oct;84 Suppl 2:ii42-8</RefSource><PMID Version="1">18799492</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2009 Dec;9(12):747-59</RefSource><PMID Version="1">19926035</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Curr Opin HIV AIDS. 2011 Mar;6(2):102-7</RefSource><PMID Version="1">21505383</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2010 Oct;26(10):1051-61</RefSource><PMID Version="1">20849299</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2008 Feb 19;22(4):503-10</RefSource><PMID Version="1">18301063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Lab Anal. 2007;21(1):40-5</RefSource><PMID Version="1">17245763</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS Med. 2011 Jun;8(6):e1001045</RefSource><PMID Version="1">21731474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2011;6(3):e17535</RefSource><PMID Version="1">21408182</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Infect Dis. 2007 Sep;11(5):459-65</RefSource><PMID Version="1">17369067</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Microbiol. 2002 Nov;40(11):4015-20</RefSource><PMID Version="1">12409368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2001 Jan 20;17(2):137-46</RefSource><PMID Version="1">11177393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sex Transm Infect. 2013 Mar;89(2):138-41</RefSource><PMID Version="1">22930346</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Sex Health. 2009 Mar;6(1):19-33</RefSource><PMID Version="1">19254488</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS Res Hum Retroviruses. 2012 Jun;28(6):532-9</RefSource><PMID Version="1">22206265</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000915" MajorTopicYN="Y">Antibody Affinity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002138" MajorTopicYN="N">Calibration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015488" MajorTopicYN="N">HIV Antigens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006679" MajorTopicYN="N">HIV Seropositivity</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012698" MajorTopicYN="N">Serologic Tests</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4339840</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>07</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25710171</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0114947</ArticleId><ArticleId IdType="pii">PONE-D-14-30403</ArticleId><ArticleId IdType="pmc">PMC4339840</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000447 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000447 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25710171
|texte= Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25710171" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |